This article is from the source 'independent' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at http://www.independent.co.uk/news/uk/medipen-the-nhs-is-testing-a-cannabis-product-vaporizer-for-the-first-time-a7191511.html
The article has changed 5 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| The NHS is testing a cannabis product for the first time | |
| (about 2 hours later) | |
| A cannabidiol vaporiser that has helped thousands of consumers suffering from a variety of conditions is being tested by an NHS unit, an unprecedented step that could increase scrutiny on cannabis’ medical benefits and have a huge impact on the UK’s draconian legislation around it. | A cannabidiol vaporiser that has helped thousands of consumers suffering from a variety of conditions is being tested by an NHS unit, an unprecedented step that could increase scrutiny on cannabis’ medical benefits and have a huge impact on the UK’s draconian legislation around it. |
| The MediPen, a completely legal way to consume CBD, which, unlike THC, is completely non-psychoactive, has been on sale for a year now and drawn very positive reviews, relieving the pain of people with everything from depression and anxiety to arthritis and fibromyalgia. | The MediPen, a completely legal way to consume CBD, which, unlike THC, is completely non-psychoactive, has been on sale for a year now and drawn very positive reviews, relieving the pain of people with everything from depression and anxiety to arthritis and fibromyalgia. |
| The company told The Independent it has been consulting with a group of production and regulatory support pharmacists from the NHS for a few months now, who have been testing their proprietary cannabis oil formulation. | The company told The Independent it has been consulting with a group of production and regulatory support pharmacists from the NHS for a few months now, who have been testing their proprietary cannabis oil formulation. |
| A detailed public report outlining the testing process and extraction methodology will follow, and though it is only about confirming purity and cannabinoid profile at this stage, this is a big first step for the medical cannabis industry in the UK. | A detailed public report outlining the testing process and extraction methodology will follow, and though it is only about confirming purity and cannabinoid profile at this stage, this is a big first step for the medical cannabis industry in the UK. |
| MediPen is confident that by setting a precedent for testing cannabis products with a reputable body like the NHS, it will have a huge impact on the public's perception of cannabis. | MediPen is confident that by setting a precedent for testing cannabis products with a reputable body like the NHS, it will have a huge impact on the public's perception of cannabis. |
| "Over the past year the MediPen has quickly become without a doubt one of the most highly-rated CBD products in the world,” commented managing director Jordan Owen. “We've recently been working very closely with a team of NHS production and regulatory support pharmacists who've been able to meticulously analyse our proprietary formulation for both safety and cannabinoid concentration. | "Over the past year the MediPen has quickly become without a doubt one of the most highly-rated CBD products in the world,” commented managing director Jordan Owen. “We've recently been working very closely with a team of NHS production and regulatory support pharmacists who've been able to meticulously analyse our proprietary formulation for both safety and cannabinoid concentration. |
| “As the UK's industry leading consumer cannabis biotechnology company, we're excited to have set a new benchmark in providing a much needed sense of legitimacy to the UK's rapidly growing legal cannabis industry." | “As the UK's industry leading consumer cannabis biotechnology company, we're excited to have set a new benchmark in providing a much needed sense of legitimacy to the UK's rapidly growing legal cannabis industry." |
| "As the first consumer cannabis product to be tested by the NHS, we are confident that this will go a long way towards creating a properly regulated cannabis market in the UK and are extremely excited to see what the future holds." | "As the first consumer cannabis product to be tested by the NHS, we are confident that this will go a long way towards creating a properly regulated cannabis market in the UK and are extremely excited to see what the future holds." |
| The NHS are unable to comment on the news at this time due to a non-disclosure agreement preventing them from sharing any client information, with the exemption of official government bodies such as the MHRA. | The NHS are unable to comment on the news at this time due to a non-disclosure agreement preventing them from sharing any client information, with the exemption of official government bodies such as the MHRA. |
| Calls for a more considered approach to cannabis legislation with medical benefits in mind have been consistently batted down by the government, the most famous recent example being a petition to legalise the drug signed by over 230,000 Brits which was debated in Parliament but dismissed out of hand. | Calls for a more considered approach to cannabis legislation with medical benefits in mind have been consistently batted down by the government, the most famous recent example being a petition to legalise the drug signed by over 230,000 Brits which was debated in Parliament but dismissed out of hand. |
| One Facebook review for the vaporiser reads: “When I thought all was lost with finding relief for my fibro I found this. It's changed my life.” You can read our review of it here. | One Facebook review for the vaporiser reads: “When I thought all was lost with finding relief for my fibro I found this. It's changed my life.” You can read our review of it here. |